Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Roche Venture Fund

VC INVESTOR TYPE
Active STATUS
5 PROFESSIONALS
125 INVESTMENTS
33 PORTFOLIO
62 EXITS
Description

The Roche Venture Fund is the corporate venture capital arm of Roche Holding. It specializes in growth capital and early stage investments. The firm prefers to invest in life sciences, pharmaceuticals, diagnostics equipment and healthcare sectors. The firm was founded in 2002 and is based in Basel, Switzerland.

Investor Status
Actively Seeking New Investments
Year Founded
2002
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland

+41 061 000 00 00

Roche Venture Fund Investments (125)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Freenome 24-Jul-2019 Early Stage VC 00000 Biotechnology Generating Revenue
0000000 0000000000 12-Jun-2019 00000 00000 000.00 Biotechnology Generating Revenue 00000000 0000 00.0
0000 00000000 25-Mar-2019 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000 000000000000 00
000000000 04-Mar-2019 00000 00000 000.00 Diagnostic Equipment Generating Revenue 000000 000000000000 00
0000 000000000000 31-Jan-2019 00000 00000 000.00 Drug Discovery Startup 0000 0000000000
0000000 0000000000 26-Sep-2018 00000 00000 000.00 Biotechnology Generating Revenue 0000 00000000 00.0
0000000 10-Sep-2018 00000 00000 0000 Biotechnology Generating Revenue 00000000 0000 00.0
000000 00000000000 26-Aug-2018 00000 00000 00.000 Drug Discovery Bankruptcy: Liquidation
Care Innovations 18-Jun-2018 Later Stage VC 000.00 Other Healthcare Services Generating Revenue
SutroVax 19-May-2018 Later Stage VC 0000 Drug Discovery Pre-Clinical Trials 00000 0000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Roche Venture Fund’s full profile, request a free trial.

Roche Venture Fund Exits (62)

Company Name Exit Date Exit Type Exit Size Status Buyers
IDEAYA Biosciences 23-May-2019 IPO 0000 Completed
000000 00000000000 13-Jan-2019 0000000000: 000000 Completed
0000000 31-Jul-2018 000000000000000000 00000 Completed
  • 000000 00000000000
0000000 19-Jul-2018 000 00000 Completed
00000000 06-Apr-2018 000000000000000000 00.00 Completed
  • 0. 00000000-00 000
0000000 17-Nov-2017 000000000000000000 Completed
  • 0. 00000000-00 000
000000 30-Jun-2017 000000000000000000 00000 Completed
  • 0. 00000000-00 000
0000000 0000000000 29-Jun-2017 000 000.00 Completed
CytomX Therapeutics 31-Mar-2017 Secondary Transaction - Open Market Completed
AveXis 16-Mar-2017 Secondary Transaction - Open Market Completed
To view this investor’s complete exits history, request access »

Roche Venture Fund Team (11)

Name Title Deals Funds Boards Office Contact
Info
Carole Nuechterlein JD Head 00 0 0 Basel, Switzerland
Anja Harmeier Ph.D Investment Director 0 0 0 Basel, Switzerland
Mitchell Mutz Ph.D Investment Director 0 0 0 Basel, Switzerland
Nisha Marathe Ph.D Investment Manager 0 0 0 Basel, Switzerland
Gabriella Zöch Project Associate Basel, Switzerland

5 Former Team Members

You’re viewing 5 of 11 team members. Get the full list »

Roche Venture Fund Co-Investors (178)

Name With Exits Lead Partner
5AM Ventures 5 0
SR One 0 0
Pfizer Ventures 0 0
New Enterprise Associates 0 0
T. Rowe Price 0 0 0
To view this investor’s complete co-investor history, request access »